ArticleClinical ophthalmology (Auckland, N.Z.)2018

Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients.

Keiko Azuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.